|
DENR expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.867800E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.482400E-01 |
| Normal-vs-Stage2 |
5.935000E-01 |
| Normal-vs-Stage3 |
3.165900E-02 |
| Normal-vs-Stage4 |
1.568200E-01 |
| Stage1-vs-Stage2 |
7.579200E-01 |
| Stage1-vs-Stage3 |
3.550400E-02 |
| Stage1-vs-Stage4 |
1.888200E-01 |
| Stage2-vs-Stage3 |
2.330200E-01 |
| Stage2-vs-Stage4 |
3.666000E-01 |
| Stage3-vs-Stage4 |
9.430800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.292000E-01 |
| Normal-vs-AfricanAmerican |
5.368300E-02 |
| Normal-vs-Asian |
3.406200E-01 |
| Caucasian-vs-AfricanAmerican |
2.798000E-01 |
| Caucasian-vs-Asian |
5.288000E-01 |
| AfricanAmerican-vs-Asian |
7.965600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.018600E-01 |
| Normal-vs-Female |
3.316800E-03 |
| Male-vs-Female |
7.995200E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.664400E-01 |
| Normal-vs-Extreme_Weight |
5.476800E-01 |
| Normal-vs-Obese |
5.602200E-02 |
| Normal-vs-Extreme_Obese |
5.071200E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.945600E-01 |
| Normal_Weight-vs-Obese |
2.503400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.350400E-01 |
| Extreme_Weight-vs-Obese |
2.082000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.497000E-01 |
| Obese-vs-Extreme_Obese |
1.592560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.061800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.856300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.379200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.203200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.508100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.257860E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.677800E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.726570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.025190E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.049600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.162810E-01 |
| Normal-VS-Type2 PRCC |
9.823800E-01 |
| Normal-VS-KIRP CIMP |
3.890400E-02 |
| Normal-VS-Unclassified PRCC |
8.697800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.115000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.140000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.249800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.918000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
8.840000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.490600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.035000E-01 |
| Normal-vs-N1 |
2.278100E-03 |
| Normal-vs-N2 |
8.449400E-01 |
| N0-vs-N1 |
1.944560E-03 |
| N0-vs-N2 |
8.210600E-01 |
| N1-vs-N2 |
1.966620E-01 |
|
|
